XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income $ 25.0 $ 86.7
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 56.1 42.6
Lease amortization expense 24.5 20.9
Non-cash interest on financing and deemed landlord financed leases 9.0 0.5
Amortization of debt discount and issuance costs 2.1 2.5
Deferred taxes, net (3.7) (12.6)
Share-based compensation 12.4 13.8
Unrealized net losses (gains) on hedging instruments and foreign currency 3.1 (0.7)
Loss on debt modification 10.5 0.0
Change in assets and liabilities:    
Accounts receivable, net (285.2) (311.4)
Inventories 30.1 (24.0)
Leasing receivables (4.3) (3.5)
Other assets 16.3 (0.8)
Accounts payable and accrued expenses 4.5 50.7
Deferred revenue 8.8 4.8
Accrued employee compensation and benefits (31.6) (20.5)
Payments on operating leases (20.5) (21.1)
Income taxes receivable/payable, net (8.5) (9.1)
Other liabilities (0.7) (4.1)
Net cash used in operating activities (152.1) (185.3)
Cash flows from investing activities:    
Capital expenditures (121.4) (124.3)
Asset acquisitions, net of cash acquired (18.4) 0.0
Acquisition of intangible assets (0.5) 0.0
Proceeds from sale of property and equipment 0.4 0.0
Net cash used in investing activities (139.9) (124.3)
Cash flows from financing activities:    
Repayments of long-term debt (775.8) (77.6)
Proceeds from borrowings on long-term debt 1,224.8 60.0
(Repayments of) proceeds from credit facilities, net (219.4) 212.2
Debt issuance cost (1.2) 0.0
Payment on contingent earn-out obligation 0.0 (5.6)
Repayments of financing leases (1.0) (0.1)
Proceeds from lease financing 51.6 50.5
Exercise of stock options 3.6 0.0
Acquisition of treasury stock (9.2) (34.3)
Net cash provided by financing activities 273.4 205.1
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0.6 (3.0)
Net decrease in cash, cash equivalents and restricted cash (18.0) (107.5)
Cash, cash equivalents and restricted cash at beginning of period 203.3 357.7
Cash, cash equivalents and restricted cash at end of period 185.3 250.2
Less: restricted cash [1] (4.7) (5.2)
Cash and cash equivalents at end of period 180.6 245.0
Supplemental disclosures:    
Cash paid for income taxes, net 9.6 8.9
Cash paid for interest and fees 35.3 21.5
Non-cash investing and financing activities:    
Issuance of treasury stock and common stock for compensatory stock awards released from restriction 21.3 24.0
Accrued capital expenditures 40.8 50.4
Financed additions of capital expenditures $ 35.8 $ 1.1
[1] (1) Includes $0.5 million and $1.0 million of short-term restricted cash and $4.2 million and $4.2 million of long-term restricted cash included in other assets for the periods ended March 31, 2023 and 2022, respectively.